Ondansetron/topiramate

Drug Profile

Ondansetron/topiramate

Alternative Names: AD-01 - ADial Pharmaceuticals; AD/TO-01

Latest Information Update: 22 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ADial Pharmaceuticals
  • Class Carbazoles; Hexoses; Imidazoles; Ketoses; Small molecules; Sulfonic acids
  • Mechanism of Action AMPA receptor antagonists; Carbonic anhydrase inhibitors; GABA A receptor agonists; Kainic acid receptor antagonists; Serotonin 3 receptor antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Alcoholism

Most Recent Events

  • 22 Feb 2016 No development reported - Phase-II for Alcoholism in USA (unspecified route)
  • 01 Apr 2013 Phase-II clinical trials in Alcoholism in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top